Cargando…

The role of pharmaceutical industry in building resilient health system

OBJECTIVES: This study explores the interrelationship among the current sustainability agenda of the pharmaceutical industry, based on the United Nation sustainable development goals (SDGs), the elements of the Joint External Evaluation (JEE) tool, and the triad components of the One Health approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Kanika, Balani, Sunita, Srivastava, Pallavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751196/
https://www.ncbi.nlm.nih.gov/pubmed/36530653
http://dx.doi.org/10.3389/fpubh.2022.964899
_version_ 1784850419615268864
author Saxena, Kanika
Balani, Sunita
Srivastava, Pallavi
author_facet Saxena, Kanika
Balani, Sunita
Srivastava, Pallavi
author_sort Saxena, Kanika
collection PubMed
description OBJECTIVES: This study explores the interrelationship among the current sustainability agenda of the pharmaceutical industry, based on the United Nation sustainable development goals (SDGs), the elements of the Joint External Evaluation (JEE) tool, and the triad components of the One Health approach. METHODS: A cross-walk exercise was conducted to identify commonalities among SDGs, JEE assessment tool, and One Health approach. An in-depth study of 10 global pharmaceutical firms' corporate sustainability reports and COVID-19 response plan for 2019–2020 was also conducted. RESULTS: The result of the exercise showed the existence of a direct and indirect relationship among the SDGs, elements of JEE assessment tool, and One Health approach. For example, both no poverty (SDG 1) and zero hunger (SDG 2) are linked with food safety targets under the JEE and with human and animal health under the One Health approach. CONCLUSION: This study adds a new dimension emphasizing the possibility of tailoring the pharmaceutical industry's activities under the sustainability agenda to strengthen global health security while remaining consistent with the One Health approach.
format Online
Article
Text
id pubmed-9751196
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97511962022-12-16 The role of pharmaceutical industry in building resilient health system Saxena, Kanika Balani, Sunita Srivastava, Pallavi Front Public Health Public Health OBJECTIVES: This study explores the interrelationship among the current sustainability agenda of the pharmaceutical industry, based on the United Nation sustainable development goals (SDGs), the elements of the Joint External Evaluation (JEE) tool, and the triad components of the One Health approach. METHODS: A cross-walk exercise was conducted to identify commonalities among SDGs, JEE assessment tool, and One Health approach. An in-depth study of 10 global pharmaceutical firms' corporate sustainability reports and COVID-19 response plan for 2019–2020 was also conducted. RESULTS: The result of the exercise showed the existence of a direct and indirect relationship among the SDGs, elements of JEE assessment tool, and One Health approach. For example, both no poverty (SDG 1) and zero hunger (SDG 2) are linked with food safety targets under the JEE and with human and animal health under the One Health approach. CONCLUSION: This study adds a new dimension emphasizing the possibility of tailoring the pharmaceutical industry's activities under the sustainability agenda to strengthen global health security while remaining consistent with the One Health approach. Frontiers Media S.A. 2022-12-01 /pmc/articles/PMC9751196/ /pubmed/36530653 http://dx.doi.org/10.3389/fpubh.2022.964899 Text en Copyright © 2022 Saxena, Balani and Srivastava. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Saxena, Kanika
Balani, Sunita
Srivastava, Pallavi
The role of pharmaceutical industry in building resilient health system
title The role of pharmaceutical industry in building resilient health system
title_full The role of pharmaceutical industry in building resilient health system
title_fullStr The role of pharmaceutical industry in building resilient health system
title_full_unstemmed The role of pharmaceutical industry in building resilient health system
title_short The role of pharmaceutical industry in building resilient health system
title_sort role of pharmaceutical industry in building resilient health system
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751196/
https://www.ncbi.nlm.nih.gov/pubmed/36530653
http://dx.doi.org/10.3389/fpubh.2022.964899
work_keys_str_mv AT saxenakanika theroleofpharmaceuticalindustryinbuildingresilienthealthsystem
AT balanisunita theroleofpharmaceuticalindustryinbuildingresilienthealthsystem
AT srivastavapallavi theroleofpharmaceuticalindustryinbuildingresilienthealthsystem
AT saxenakanika roleofpharmaceuticalindustryinbuildingresilienthealthsystem
AT balanisunita roleofpharmaceuticalindustryinbuildingresilienthealthsystem
AT srivastavapallavi roleofpharmaceuticalindustryinbuildingresilienthealthsystem